남은미 교수는 의학전문대학원 내과학교실 소속의 교수로 혈액종양학을 전공하여 현재 이대목동병원 혈액종양내과에서 주로 대장암, 간담도암, 췌장암 환자를 진료하고 있다. 지난 2011년 미국 Fred Hutchinson Cancer Research Center에서 1년간 연수하면서 대장암분야의 연구를 진행한 바 있으며 현재는 임상암학회 학술위원으로 활동 중이다.
Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trialBMC Cancer, 2023, v.23 no.1, 734
Association of illness understanding with advance care planning and end-of-life care preferences for advanced cancer patients and their family membersSUPPORTIVE CARE IN CANCER, 2020, v.28 no.6, 2959-2967
Peroxiredoxin 3 has important roles on arsenic trioxide induced apoptosis in human acute promyelocytic leukemia cell line via hyperoxidation of mitochondrial specific reactive oxygen speciesMolecules and Cells, 2020, v.43 no.9, 813-820
Attitudes of the General Public, Cancer Patients, Family Caregivers, and Physicians Toward Advance Care Planning: A Nationwide Survey Before the Enforcement of the Life-Sustaining Treatment Decision-Making ActJOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2019, v.57 no.4, 774-782
Do Korean Medical Schools Provide Adequate End-of-Life Care Education? A Nationwide Survey of the Republic of Korea’s End-of-Life Care Curricula한국호스피스완화의료학회지, 2019, v.22 no.4, 207~218
Efficacy of a Decision Aid Consisting of a Video and Booklet on Advance Care Planning for Advanced Cancer Patients: Randomized Controlled TrialJournal of Pain and Symptom Management, 2019, v.58 no.6, 940-9.48E04
Factors That Influence Attitudes Toward End-of-Life Care Among Medical Students: Nationwide Survey for Fourth-Year Korean Medical StudentsAMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2019, v.36 no.6, 460-465
Mapping of local recurrence after pancreaticoduodenectomy for distal extrahepatic cholangiocarcinoma: implications for adjuvant radiotherapyBRITISH JOURNAL OF RADIOLOGY, 2019, v.92 no.1100, 20190285
The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-04 studyThe Korean journal of internal medicine, 2019, v.34 no.1, 165-177
Comparison of attitudes towards five end-of-life care interventions (active pain control, withdrawal of futile life-sustaining treatment, passive euthanasia, active euthanasia and physician-assisted suicide): a multicentred cross-sectional survey of Korean patients with cancer, their family caregivers, physicians and the general Korean populationBMJ OPEN, 2018, v.8 no.9, e020519
Discordance between Physician and the General Public Perceptions of Prognostic Disclosure to Children with Serious Illness: a Korean Nationwide StudyJOURNAL OF KOREAN MEDICAL SCIENCE, 2018, v.33 no.49, UNSP e327
Prognostic significance of survivin expression and combined analysis with cancer stem cell and epithelial–mesenchymal transition-related markers in patients with rectal cancer undergoing preoperative chemoradiotherapyAnticancer Research, 2018, v.38 no.12, 6881-6889
Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapyInternational Journal of Clinical Oncology, 2017, v.22 no.6, 1-7
Germ Cell Tumor Targeting Chemotherapy in Gastric Adenocarcinoma with an Endodermal Sinus Tumor Component: A Case ReportChemotherapy, 2016, June 29, 2016, 54-57
MITOCHONDRIAL SPECIFIC ROS HYPEROXIDATION VIA PEROXIREDOXIN III HAS IMPORTANT ROLES ON ARSENIC TRIOXIDE INDUCED APOPTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIAHAEMATOLOGICA, 2016, v.101, 672-672
Phase II study of mFOLFOX3 (5-fluorouracil, leucovorin, oxaliplatin) as second-line treatment after gemcitabine failure in patients with unresectable/metastatic biliary tract cancerCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, v.75 no.4, 757-762
CpG Island Methylator Phenotype Is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage III Colon CancerGASTROENTEROLOGY, 2014, v.147 no.3, 637-645
Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patientsCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, v.73 no.1, 125-130
Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancerTUMORI, 2014, v.100 no.1, 80-86
Treatment outcomes of gemcitabine alone versus gemcitabine plus platinum for advanced biliary tract cancer: a Korean Cancer Study Group retrospective analysisCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, v.74 no.6, 1291-1296